Australian Health Minister replaced

13 December 2011

Australian Prime Minister Julia Gillard on Monday reshuffled her cabinet to bring in "fresh blood" after what has been a difficult year in which her government has languished in opinion polls.

The changes, announced by Ms Gillard during a Canberra press conference yesterday, increase the size of her cabinet from 20 to 22 and confirm Australia will have its first ever female Attorney-General. That portfolio will be taken by Nicola Roxon who once worked as a High Court judge's associate, but until yesterday held the post of Minister for Health and Ageing.

Ms Roxon will be replaced by Tanya Plibersek as Minister for Health and Greg Combet will become Minister for Industry and Innovation, replacing Kim Carr, it was announced by the Premier.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >